Myofascial pain syndrome (MAS) is defined as a regional painful syndrome characterized by pain and tenderness in a muscle group or a muscle, a taut band within the muscle, pain reflected by pressing, and the presence of trigger points. It causes localized muscle pain in the shoulder and neck. The frequency of mas is around 12% in the normal population, and its frequency increases in those with chronic diseases. It is more common in the 30-60 age range and in the female population. Mechanical causes such as micro-macro trauma, nociceptive disorders, physical fatigue, psychological stress and genetic factors are blamed in its etiopathogenesis. Painful myofascial trigger points may occur by pressing on all muscles in the body, although it is more common in the trazius muscle, especially in those who work at a desk, who are constantly in a certain position, and who are sedentary. Myofascial trigger points are often detected by examination.

There is a difference between the pain, neck extension range of motion, neck functional status of 3 different dry needling methods used in routine treatment in patients with myofascial pain syndrome. The investigators set out by thinking which method is more appropriate to choose in our practice. When the investigators examined the literature, the investigators could not find a study comparing these methods. However, at the points where sham needling, lidocaine administration, ozone cost, kinesiotaping methods and dry needling are compared by using these methods separately, regardless of the method of dry needling, there is a significant improvement in functional status, pain score, attachments, improvement expenses in the range of motion. However, the investigators think that it will contribute to a study literature on the protection of these purposes more clearly.

Inclusion Criteria:

• Among the patients who applied to Sultan 2. Abdulhamid Han Hospital Physical Medicine and Rehabilitation Department and were diagnosed with myofascial pain syndrome
• Decided to receive dry needling treatment
• Between the ages of 18 and 65
• At least 1 painful myofascial trigger point in the m.trapezius, m.levator scapula muscles
• Patients with neck pain lasting less than 6 months

Exclusion Criteria:

• Those with a history of cervical operation
• Those who have a history of shoulder operation
• Patients with radiculopathy as a result of the examination
• Those who have been injected into the determined area in the last 3 months
• Those diagnosed with fibromyalgia according to the 2018 fibromyalgia scale
• Those with cervical disc herniation in the MR imaging taken within the last 1 year
• Pregnant/pregnant women
• Those who are allergic to silver
• Those with a history of malignancy
• Those with positive red flags
• Those with known rheumatological disease
• Those who do not accept dry needling
• Those with cognitive impairment
• Those who have local infection in the application area